Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter

Investor News

Clinical Development News
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
Approvable Letters
Approval and Marketing Clearance
Recalls and Warnings

Deals & Dollars News
Earnings Reports
Mergers and Acquisitions

IPO News

Clinical - BLA/NDA/ANDA
U.S. Approval Of Merck & Co., Inc. (MRK) Cancer Immunotherapy Expected Soon 8/25/2014 6:16:29 AM
Alkermes plc (ALKS) Submits New Drug Application To FDA For Aripiprazole Lauroxil For Treatment Of Schizophrenia 8/25/2014 9:03:29 AM
Supernus Pharmaceuticals (SUPN) Announces Paragraph IV ANDA Filing for Trokendi XR® 8/21/2014 7:54:43 AM
Aeolus Pharmaceuticals Inc. (AOLS.OB) Files Investigational New Drug Application With U.S FDA To Enable Initiation Of Human Safety Studies For The Development Of AEOL 10150 As A Medical Countermeasure Against Lung Damage From Radiation Exposure 8/20/2014 11:20:07 AM
FDA Tentatively Approves Boehringer Ingelheim Corporation, Eli Lilly and Company (LLY)'s Basaglar™ 8/18/2014 3:54:05 PM
Boehringer Ingelheim Pharmaceuticals, Inc. Announces U.S. Filing For The Fixed-Dose Combination Tiotropium Plus Olodaterol For Patients With COPD 8/19/2014 8:14:39 AM
Bioniche Life Sciences Inc. (BNC) Announces Q1/2015 Timeline For The Filing Of A Biologics License Application For Marketing Approval Of MCNA In The United States 8/19/2014 7:56:56 AM
Pfizer Inc. (PFE) Announces Submission Of Palbociclib New Drug Application To The FDA 8/18/2014 8:08:54 AM
ARCA biopharma Announces Health Canada Acceptance Of Genetic-AF Clinical Trial Application 8/18/2014 8:06:25 AM
FDA Continues To Seek More Data On Acura Pharmaceuticals, Inc. (ACUR)'s Abuse-Resistant Pain Drug 8/15/2014 6:26:40 AM
Pfizer Inc. (PFE)'s License Application For Meningococcal B Accepted By The FDA 8/15/2014 6:55:36 AM
Celltrion, Inc. (068270.KQ) Files For Approval Of Remicade Biosimilar In US 8/13/2014 12:34:01 PM
INSYS Therapeutics Submits NDA For Its New Oral Formulation Of Dronabinol 8/12/2014 3:04:15 PM
BioDelivery Sciences International (BDSI) Announces BEMA Buprenorphine NDA Submission On Track Following Pre-NDA Meeting With FDA 8/12/2014 8:26:49 AM
Kythera Biopharmaceuticals (KYTH) Submits New Drug Submission To Health Canada For ATX-101 As First-In-Class Treatment For The Reduction Of Submental Fat 8/11/2014 5:24:44 PM